List of insiders holdings for COLLEGIUM PHARMACEUTICAL INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Skyline Venture Partners V LP Skyline Venture Management V LLC 10% Owner | 2017-12-07 19:03:10 | 2,949,916 0 | 2,949,916 | Form 4 |
| TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G Former 10% Owner | 2017-02-13 15:13:01 | 1,389,863 0 | 1,389,863 | Form 13G |
| Frazier Healthcare VI L.P. FHM VI L.P. FHM VI L.L.C. FRAZIER ALAN D Naini Nader J Topper James N Every Nathan R 10% Owner | 2020-01-24 13:38:25 | 1,132,399 0 | 1,132,399 | Form 13D |
| KANEKO YASUNORI 10% Owner | 2017-12-07 19:05:08 | 0 800,540 | 800,540 | Form 4 |
| Ciaffoni Joseph President and CEO | 2024-02-14 16:13:23 | 444,867 0 | 444,867 | Form 4 |
| Karnani Vikram President and CEO | 2024-11-14 16:50:17 | 236,316 0 | 236,316 | Form 4 |
| Brannelly Paul Executive Vice President & CFO | 2021-02-12 16:14:28 | 215,428 0 | 215,428 | Form 4 |
| Longitude Capital Partners LLC Tammenoms Bakker Juliet ENRIGHT PATRICK G Longitude Capital Associates L.P. Longitude Venture Partners L.P. 10% Owner | 2019-02-12 17:12:32 | 158,043 0 | 158,043 | Form 13G |
| Fleming Alison B EVP & Chief Technical Officer | 2021-08-12 16:03:18 | 143,694 0 | 143,694 | Form 4 |
| Tupper Colleen EVP & Chief Financial Officer | 2024-05-29 16:29:04 | 130,845 0 | 130,845 | Form 4 |
| Malamut Richard EVP and Chief Medical Officer | 2022-02-14 18:49:23 | 130,264 0 | 130,264 | Form 4 |
| Dreyer Scott EVP & Chief Commercial Officer | 2024-05-28 16:22:47 | 129,693 0 | 129,693 | Form 4 |
| Kuhlmann Shirley R. EVP and General Counsel | 2024-09-06 17:52:56 | 119,184 0 | 119,184 | Form 4 |
| Freund John Gordon Director | 2024-05-16 19:22:42 | 52,468 43,413 | 95,881 | Form 4 |
| Carlson Douglas R VP Corp. Devlp | 2015-05-06 16:16:52 | 89,720 0 | 89,720 | Form 3 |
| Kopecky Ernest A see remarks | 2015-05-06 16:18:04 | 80,770 0 | 80,770 | Form 3 |
| SANTINI GINO Director | 2024-05-16 19:23:49 | 75,656 0 | 75,656 | Form 4 |
| Fallon John A. Director | 2024-05-16 19:22:21 | 54,843 0 | 54,843 | Form 4 |
| Smith Thomas B EVP and Chief Medical Officer | 2024-09-17 16:32:05 | 53,816 0 | 53,816 | Form 4 |
| BOHLIN GAREN G Director | 2024-05-16 19:20:35 | 52,468 0 | 52,468 | Form 4 |
| Melincoff Gwen A Director | 2024-05-16 19:23:27 | 52,468 0 | 52,468 | Form 4 |
| McFarlane Neil F. Director | 2024-05-16 19:23:00 | 49,365 0 | 49,365 | Form 4 |
| Balice-Gordon Rita J. Director | 2024-05-16 19:22:01 | 46,488 0 | 46,488 | Form 4 |
| Heffernan Michael Thomas Director | 2024-05-16 19:21:42 | 45,508 0 | 45,508 | Form 4 |
| Hirsch David Director | 2020-05-22 16:24:39 | 29,259 0 | 29,259 | Form 4 |
| Saim Said VP, Pharmaceutical Devlp. | 2015-05-06 16:13:21 | 25,883 0 | 25,883 | Form 3 |
| Duke Barry S See remarks | 2017-03-21 16:43:20 | 20,087 0 | 20,087 | Form 4 |
| Schroeder Theodore R Director | 2020-05-22 16:22:11 | 19,102 0 | 19,102 | Form 4 |
| Heron Patrick J Director 10% Owner | 2015-09-14 16:02:28 | 15,000 0 | 15,000 | Form 4 |
| Nadav Eran Director | 2016-06-13 17:47:10 | 8,700 0 | 8,700 | Form 4 |